Moderna's coronavirus vaccine just showed signs of success in a preliminary study,
* Moderna released the first human results from its coronavirus vaccine candidate on Monday.
* In a small number of healthy volunteers, Moderna's vaccine helped create immune responses that may help protect people from being infected with the novel coronavirus.Â
* The biotech is planning to start additional trials immediately and is aiming to be ready this fall for potential emergency use of its vaccine.
* Visit Business Insider's homepage for more stories.
In a milestone moment in the race for a coronavirus vaccine, the first results in humans showed Moderna's vaccine candidate led to antibody responses in a handful of healthy volunteers.Â
The Massachusetts biotech described Monday the immune system responses to the vaccine from this first, small study that was primarily focused on safety. The results don't yet show whether the vaccine would prevent people from being infected with the novel coronavirus.
Finding an effective coronavirus vaccine has become a global priority in ending the pandemic. US government leaders have put forward the ambitious timeline to have one by the end of 2020. It typically takes several years to develop a vaccine.
The trial was conducted by the US National Institutes of Health. Moderna is planning to soon start a mid-stage study and then begin a late-stage trial in July. The company is aiming to be ready for potential emergency use of its vaccine this fall, a timeline with no precedent in the history of vaccine development.
http://www.businessinsider.com/moderna-coronavirus-vaccine-releases-first-human-trial-results-2020-5
| 
